Allied Market Research

2024

Oral Dissolvable Films Market

Oral Dissolvable Films Market Size, Share, Competitive Landscape and Trend Analysis Report by Product and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Oral drug delivery is an essential part of drug delivery and pharmaceutical industry. People with a condition called dysphagia (difficulty in swallowing) require oral administration of drugs. Thus, oral thin film medication are developed for swift oral administration of drugs. To improve patient compliance various types of vaccines and hormones are developed by the market players.

Technological advancement in drug discovery and development processes, less bio-availability of solid drugs, and inaccurate dosage by liquid formulations is expected to boost the market growth for oral dissolvable films market. However, challenges related to drug development and massive research investment required for creation of simple and novel formulation is expected to hinder the market.

The global oral dissolvable films market is segmented on the basis of product, application, and geography. Based on product, the market is classified into oral dispersible, sublingual, and buccal. Based on application, the market is divided into pharma & healthcare and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub-segment.

Comprehensive competitive analysis and profiles of major market players such as MonoSol Rx, Tesa Labtec GmbH, IntelGenX, BioDelivery Sciences, Cynapsus Therapeutics Inc, FFT Medical, Innoteq, Acadia Pharmaceuticals Inc, Neuroderm Ltd., and Transition Therapeutics, Inc. are provided in this report.

Key Benefits :

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
  • It offers a quantitative analysis¬†to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Oral Dissolvable Films Market Report Highlights

Aspects Details
icon_5
By Product
  • Oral Dispersible
  • Sublingual
  • Buccal
icon_6
By Application
  • Pharma & Healthcare
  • Others
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Turkey, Rest of LAMEA)
icon_8
Key Market Players

Acadia Pharmaceuticals Inc,, Innoteq,, Transition Therapeutics, Inc., IntelGenX,, Cynapsus Therapeutics Inc,, Neuroderm Ltd., BioDelivery Sciences,, FFT Medical,, MonoSol Rx,, Tesa Labtec GmbH

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Oral Dissolvable Films Market

Global Opportunity Analysis and Industry Forecast, 2023-2032